Use of rFVIIa for critical bleeding in cardiac surgery: Dose variation and patient outcomes

Vox Sanguinis

Volumn 98, Issue 4, 2010, Pages 531-537

  Willis, C ^a   Bird, R ^b   Mullany, D ^c   Cameron, P ^a   Phillips, L ^a  

^a ALFRED HOSPITAL   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

Cardiac surgery; Dose; Factor VIIa; Haemostasis; NovoSeven

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7A; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE REGISTRY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART SURGERY; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OFF LABEL DRUG USE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SURGICAL MORTALITY; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TREATMENT RESPONSE; HEMORRHAGE; MIDDLE AGED;

AGED; CARDIAC SURGICAL PROCEDURES; FACTOR VIIA; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 77951129024     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2009.01276.x     Document Type: Article

References (22)

1. Karkouti K, Beattie WS, Wijeysundera DN, Yau TM, McCluskey SA, Ghannam M, Sutton D, van Rensburg A, Karski J : Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis. Transfusion 2005 45 : 26 34
2. Loudon B, Smith MP : Recombinant factor VIIa as an adjunctive therapy for patients requiring large volume transfusion: a pharmacoeconomic evaluation. Intern Med J 2005 35 : 463 467
3. Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M : Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiov Sur 1996 111 : 1037 1046 (Pubitemid 26146058)
4. Karkouti K, Beattie WS, Arellano R, Aye T, Bussieres JS, Callum JL, Cheng D, Heinrich L, Kent B, Lee TWR, MacAdams C, Mazer CD, Muirhead B, Rochon AG, Rubens FD, Sawchuk C, Wang S, Waters T, Wong BI, Yau TM : Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery. Circulation 2008 118 : 331 338
5. Raivio P, Suojaranta-Ylinen R, Kuitunen AH : Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. Ann Thorac Surg 2005 80 : 66 71 (Pubitemid 40840184)
6. Tritapepe L, De Santis V, Vitale D, Nencini C, Pellegrini F, Landoni G, Toscano F, Miraldi F, Pietropaoli P : Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis. Crit Care Med 2007 35 : 1685 1690 (Pubitemid 46985870)
7. Bishop CV, Renwick WEP, Hogan C, Haeusler M, Tuckfield A, Tatoulis J : Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery. Ann Thorac Surg 2006 81 : 875 879 (Pubitemid 43247653)
8. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T : Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. New Engl J Med 2008 358 : 2127 2137 (Pubitemid 351679599)
9. Lusher JM, Roberts HR, Davignon G, Joist JH, Smith H, Shapiro A, Laurian Y, Kasper CK, Mannucci PM : A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group. Haemophilia 1998 4 : 790 798 (Pubitemid 28561369)
10. Romagnoli S, Bevilacqua S, Gelsomino S, Pradella S, Ghilli L, Rostagno C, Gensini GF, Sorbara C : Small-dose recombinant activated factor VII (NovoSeven) in cardiac surgery. Anesth Analg 2006 102 : 1320 1326
11. O'Connell NM, Perry DJ, Hodgson AJ, O'Shaughnessy DF, Laffan MA, Smith OP : Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 2003 43 : 1711 1716
12. Johnson SJ, Ross MB, Moores KG : Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery. Am J Health-Syst Ph 2007 64 : 1808 1812 (Pubitemid 350202212)
13. Gelsomino S, Lorusso R, Romagnoli S, Bevilacqua S, De Cicco G, Billè G, Stefàno P, Gensini GF : Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis. Eur J Cardio-Thorac 2008 33 : 64 71 (Pubitemid 350266356)
14. Gill R, Herbertson M, Vuylsteke A, Skov Olsen P, von Heymann C, Mythen M, Sellke F, Booth F, Andersen Schmidt T : Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009 120 : 21 28
15. Karkouti K : Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery. Can J Anaesth 2006 53 : 802 809 (Pubitemid 44420066)
16. Harrison TD, Laskosky J, Jazaeri O, Pasquale MD, Cipolle M : "Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage. J Trauma 2005 59 : 150 154 (Pubitemid 41271655)
17. McCall P, Story DA, Karapillai D : Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery. Can J Anaesth 2006 53 : 926 933 (Pubitemid 44696517)
18. Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T : Recombinant activated factor VII in cardiac surgery: a systematic review. Ann Thorac Surg 2007 83 : 707 714 (Pubitemid 46138055)
19. Levy JH, Fingerhut A, Brott T, Langbakke IH, Erhardtsen E, Porte RJ : Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion 2006 46 : 919 933 (Pubitemid 43800910)
20. Bowman LJ, Uber WE, Stroud MR, Christiansen LR, Lazarchick J, Crumbley AJ, Kratz JM, Toole JM, Crawford FA, Ikonomidis JS : Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery. Ann Thorac Surg 2008 85 : 1669 1676
21. Hyllner M, Houltz E, Jeppsson A : Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery. Eur J Cardio-Thorac 2005 28 : 254 258 (Pubitemid 41020693)
22. von Heymann C, Redlich U, Jain U, Kastrup M, Schroeder T, Sander M, Grosse J, Ziemer S, Koscielny J, Konertz WF, Wernecke K-D, Spies C : Recombinant activated factor VII for refractory bleeding after cardiac surgery - a retrospective analysis of safety and efficacy. Crit Care Med 2005 33 : 2241 2246 (Pubitemid 41437477)